<VariationArchive RecordType="classified" VariationID="997018" VariationName="NM_020232.5(PSMG2):c.666_667del (p.Tyr223fs)" VariationType="Deletion" Accession="VCV000997018" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2021-02-20" MostRecentSubmission="2021-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="984731" VariationID="997018">
      <GeneList>
        <Gene Symbol="PSMG2" FullName="proteasome assembly chaperone 2" GeneID="56984" HGNC_ID="HGNC:24929" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>18p11.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="12658738" stop="12725740" display_start="12658738" display_stop="12725740" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="12658737" stop="12725738" display_start="12658737" display_stop="12725738" Strand="+" />
          </Location>
          <OMIM>609702</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_020232.5(PSMG2):c.666_667del (p.Tyr223fs)</Name>
      <CanonicalSPDI>NC_000018.10:12724582:GT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>18p11.21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="12724583" stop="12724584" display_start="12724583" display_stop="12724584" variantLength="2" positionVCF="12724582" referenceAlleleVCF="AGT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="12724582" stop="12724583" display_start="12724582" display_stop="12724583" variantLength="2" positionVCF="12724581" referenceAlleleVCF="AGT" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>Y192fs</ProteinChange>
      <ProteinChange>Y223fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.10" sequenceAccession="NC_000018" sequenceVersion="10" change="g.12724583_12724584del" Assembly="GRCh38">
            <Expression>NC_000018.10:g.12724583_12724584del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.9" sequenceAccession="NC_000018" sequenceVersion="9" change="g.12724582_12724583del" Assembly="GRCh37">
            <Expression>NC_000018.9:g.12724582_12724583del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020232.5" sequenceAccession="NM_020232" sequenceVersion="5" change="c.666_667del" MANESelect="true">
            <Expression>NM_020232.5:c.666_667del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_064617.2" sequenceAccession="NP_064617" sequenceVersion="2" change="p.Tyr223fs">
            <Expression>NP_064617.2:p.Tyr223fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_147163.2" sequenceAccession="NM_147163" sequenceVersion="2" change="c.573_574del">
            <Expression>NM_147163.2:c.573_574del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_671692.1" sequenceAccession="NP_671692" sequenceVersion="1" change="p.Tyr192fs">
            <Expression>NP_671692.1:p.Tyr192fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="609702.0001" DB="OMIM" />
        <XRef Type="rs" ID="2040458488" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_020232.5(PSMG2):c.666_667del (p.Tyr223fs) AND Proteasome-associated autoinflammatory syndrome 4" Accession="RCV001291936" Version="1">
        <ClassifiedConditionList TraitSetID="65514">
          <ClassifiedCondition DB="MedGen" ID="C5543053">Proteasome-associated autoinflammatory syndrome 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-02-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-02-17" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-02-20" MostRecentSubmission="2021-02-20">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">30664889</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="65514" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="55830" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Proteasome-associated autoinflammatory syndrome 4</ElementValue>
                <XRef ID="MONDO:0030931" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PRAAS4</ElementValue>
                <XRef Type="MIM" ID="619183" DB="OMIM" />
              </Symbol>
              <XRef ID="C5543053" DB="MedGen" />
              <XRef ID="MONDO:0030931" DB="MONDO" />
              <XRef Type="MIM" ID="619183" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2918328" SubmissionDate="2021-02-17" DateLastUpdated="2021-02-20" DateCreated="2021-02-20">
        <ClinVarSubmissionID localKey="609702.0001_PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 4 (1 patient)" title="PSMG2, 2-BP DEL, 666GT_PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 4 (1 patient)" />
        <ClinVarAccession Accession="SCV001480490" DateUpdated="2021-02-20" DateCreated="2021-02-20" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-02-17">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 9-year-old girl with proteasome-associated autoinflammatory syndrome-4 (PRAAS4; 619183), de Jesus et al. (2019) identified compound heterozygous mutations in the PSMG2 gene: a 2-bp deletion (c.666_667delGT, NM_020232), resulting in a frameshift and premature termination (Tyr223SerfsTer2), and a c.675T-G transversion, resulting in an asn225-to-lys (N225K; 609702.0002) substitution. The mutations, which were found by whole-exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. Neither was present in public databases, including gnomAD. Patient fibroblasts showed decreased proteolytic activity of the proteasome, resulting in abnormal accumulation of ubiquitinated proteins. There was decreased expression of both PSMG2 and PSMG1 (605296), as well as decreased assembled proteasome complexes, suggesting impaired assembly of the proteasome. The findings were consistent with a loss-of-function effect.</Attribute>
              <Citation>
                <ID Source="PubMed">30664889</ID>
              </Citation>
              <XRef DB="OMIM" ID="619183" Type="MIM" />
              <XRef DB="OMIM" ID="605296" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PSMG2" />
          </GeneList>
          <Name>PSMG2, 2-BP DEL, 666GT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 666GT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="609702.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 4 (1 patient)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
  </ClassifiedRecord>
</VariationArchive>

